NEW YORK (GenomeWeb News) – Oxford Gene Technology said today that it has acquired Cytocell for an undisclosed sum.

Cytocell, based in Cambridge, UK, offers a portfolio of fluorescence in situ hybridization probes that can be used to detect gene arrangements related to inherted diseases and cancer. Oxford, UK-based OGT said that Cytocell's products complement its CytoSure cytogenetics array and next-generation sequencing products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: new gene linked to ocular coloboma, new statistical model for interrogating gene expression networks, and more.

With a new collection, PLOS highlights negative results it has published.

A pair of researchers examines political leanings and views on genomics, finding more of a role for optimism and pessimism in people's views.

The genome of the carnivorous bladderwort is smaller than many other plant genomes, but it still holds on to important genes.